Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial - Concepedia

Concepedia

Publication | Closed Access

Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

255

Citations

28

References

2002

Year

P. Kosmidis, Nick Mylonakis, C. Nicolaides, C. Kalophonos, Epaminontas Samantas, J. Boukovinas, George Fountzilas, Dimosthenis Skarlos, T. Economopoulos, D. Tsavdaridis,

Journal of Clinical Oncology

Abstract

The PG combination is as equally active and well tolerated as the PC combination in patients with advanced NSCLC.

References

	Year	Citations

Page 1